
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+3
Aurisco Pharmaceutical Co., Ltd. was founded in 1998, focusing on the production and sales of complex APIs, FDFs and CRDMO of oligonucleotide APIs. It has been listed on the main board of Shanghai Stock Exchange since 2020 (stock code 605116). The company currently has 3 factories, 6 R&D centers, more than 1,300 employees and around 240 R&D personnel. It takes a leading position in the field of complex synthesis, synthetic biology, oligonucleotide synthesis, photochemistry and other fields and has become a long-term partner of many world-renowned pharmaceutical companies. With international compliant quality system, sufficient production capacity, global sales network, we...
Api,fdf, complex synthesis,synthetic biology,oligonucleotide synthesis,photochemistry,cdmo,and cro
Aurisco pharmaceutical co.,ltd operates in the Pharmaceutical manufacturing industry.
Aurisco pharmaceutical co.,ltd's revenue is 101m - 500m
Aurisco pharmaceutical co.,ltd has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.